oxycodone hydrochloride · Knoa Pharma · NDA 022272
Oxycontin
Earliest generic entry, as listed · earliest of 7 marketed strengths
24 Aug 2027
Other strengths are listed to 29 Mar 2030.
Blocked by patent: US 11304908, US 11304909, US 11964056, US 12246094, US 12280152, US 8808741, US 8894988, US 9492389, US 9492391, US 9492392, US 9492393, US 9763933, US 9770416, US 9775808.
Listed patents · 15 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8894987 | product | 29 Mar 2030 |
| US 11304908 | product | 24 Aug 2027 |
| US 11304909 | use U-1556 | 24 Aug 2027 |
| US 11964056 | product | 24 Aug 2027 |
| US 12246094 | product | 24 Aug 2027 |
| US 12280152 | product | 24 Aug 2027 |
| US 8808741 | use U-1556 | 24 Aug 2027 |
| US 8894988 | product | 24 Aug 2027 |
| US 9492389 | product | 24 Aug 2027 |
| US 9492391 | use U-1556 | 24 Aug 2027 |
| US 9492392 | product | 24 Aug 2027 |
| US 9492393 | use U-1556 | 24 Aug 2027 |
| US 9763933 | product | 24 Aug 2027 |
| US 9770416 | product | 24 Aug 2027 |
| US 9775808 | product | 24 Aug 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Enters 12-month window basis: patent · 022272-00724 Aug 2027
- 24 Oct 2026Enters 12-month window basis: patent · 022272-00624 Aug 2027
- 24 Oct 2026Enters 12-month window basis: patent · 022272-00524 Aug 2027
Products covered · 7
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022272 · 001 · RLD | tablet, extended release, oral | 10MG | 29 Mar 2030 |
| 022272 · 002 · RLD | tablet, extended release, oral | 15MG | 29 Mar 2030 |
| 022272 · 003 · RLD | tablet, extended release, oral | 20MG | 29 Mar 2030 |
| 022272 · 004 · RLD | tablet, extended release, oral | 30MG | 29 Mar 2030 |
| 022272 · 005 · RLD | tablet, extended release, oral | 40MG | 24 Aug 2027 |
| 022272 · 006 · RLD | tablet, extended release, oral | 60MG | 24 Aug 2027 |
| 022272 · 007 · RLD | tablet, extended release, oral | 80MG | 24 Aug 2027 |